Clinical Trial Update: Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating add-on spironolactone to losartan versus losartan alone on the peritoneal membrane in peritoneal dialysis patients with end-stage renal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Peritoneal Dialysis

Drugs mentioned

• Losartan (losartan)
• Spironolactone (spironolactone)

Snippet

Sponsor: Chiang Mai University | Conditions: End Stage Renal Disease, Peritoneal Dialysis | Phase 4 | Status: UNKNOWN